1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted

2. Executive Summary
2.1. Market Snapshot: Global Metabolomics Market
2.2. Global Metabolomics Market, By Product and Services, 2023 (US$ Million)
2.3. Global Metabolomics Market, By Application, 2023 (US$ Million)
2.4. Global Metabolomics Market, By Indication, 2023 (US$ Million)
2.5. Global Metabolomics Market, By Geography, 2023 (US$ Million)
2.6. Attractive Investment Proposition by Geography, 2023

3. Metabolomics Market: Competitive Analysis
3.1. Market Positioning of Key Metabolomics Market Vendors
3.2. Strategies Adopted by Metabolomics Market Vendors
3.3. Key Industry Strategies
4. Metabolomics Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Metabolomics Market Value, 2022 - 2032, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis
4.6. Porter's Five Force Model
4.6.1. Supplier Power
4.6.2. Buyer Power
4.6.3. Threat Of Substitutes
4.6.4. Threat Of New Entrants
4.6.5. Competitive Rivalry
4.7. PESTEL Analysis
4.7.1. Political Landscape
4.7.2. Economic Landscape
4.7.3. Technology Landscape
4.7.4. Legal Landscape
4.7.5. Social Landscape

5. Metabolomics Market: By Product and Services, 2022-2032, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2023 Versus 2032
5.3. Market Segmentation
5.3.1. Metabolomic Instruments
5.3.1.1. Separation Tools
5.3.1.1.1. Gas Chromatography
5.3.1.1.2. Ultra-Performance Liquid Chromatography
5.3.1.1.3. Capillary Electrophoresis
5.3.1.2. Detection Tools
5.3.1.2.1. Mass Spectrometry
5.3.1.2.2. Nuclear Magnetic Resonance Spectroscopy
5.3.1.2.3. Surface-Based Mass Analysis
5.3.2. Metabolomics Bioinformatics Tools and Services
5.3.2.1. Bioinformatics Tools & Databases
5.3.2.2. Bioinformatics Services

6. Metabolomics Market: By Application, 2022-2032, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2023 Versus 2032
6.3. Market Segmentation
6.3.1. Biomarker Discovery
6.3.2. Drug Discovery
6.3.3. Functional Genomics
6.3.4. Personalized Medicine
6.3.5. Toxicology Testing
6.3.6. Nutrigenomics
6.3.7. Others

7. Metabolomics Market: By Indication, 2022-2032, USD (Million)
7.1. Market Overview
7.2. Growth & Revenue Analysis: 2023 Versus 2032
7.3. Market Segmentation
7.3.1. Cancer
7.3.2. Cardiovascular Disorders
7.3.3. Neurological Disorders
7.3.4. Inborn Errors of Metabolism
7.3.5. Others


8. North America Metabolomics Market, 2022-2032, USD (Million)
8.1. Market Overview
8.2. Metabolomics Market: By Product and Services, 2022-2032, USD (Million)
8.3. Metabolomics Market: By Application, 2022-2032, USD (Million)
8.4. Metabolomics Market: By Indication, 2022-2032, USD (Million)
8.5.Metabolomics Market: By Region, 2022-2032, USD (Million)
8.5.1.North America
8.5.1.1. U.S.
8.5.1.1.1. Metabolomics Market: By Product and Services, 2022-2032, USD (Million)
8.5.1.1.2. Metabolomics Market: By Application, 2022-2032, USD (Million)
8.5.1.1.3. Metabolomics Market: By Indication, 2022-2032, USD (Million)
8.5.1.2. Canada
8.5.1.2.1. Metabolomics Market: By Product and Services, 2022-2032, USD (Million)
8.5.1.2.2. Metabolomics Market: By Application, 2022-2032, USD (Million)
8.5.1.2.3. Metabolomics Market: By Indication, 2022-2032, USD (Million)
8.5.1.3. Rest of North America
8.5.1.3.1. Metabolomics Market: By Product and Services, 2022-2032, USD (Million)
8.5.1.3.2. Metabolomics Market: By Application, 2022-2032, USD (Million)
8.5.1.3.3. Metabolomics Market: By Indication, 2022-2032, USD (Million)

9. UK and European Union Metabolomics Market, 2022-2032, USD (Million)
9.1. Market Overview
9.2. Metabolomics Market: By Product and Services, 2022-2032, USD (Million)
9.3. Metabolomics Market: By Application, 2022-2032, USD (Million)
9.4. Metabolomics Market: By Indication, 2022-2032, USD (Million)
9.5.Metabolomics Market: By Region, 2022-2032, USD (Million)
9.5.1.UK and European Union
9.5.1.1. UK
9.5.1.1.1. Metabolomics Market: By Product and Services, 2022-2032, USD (Million)
9.5.1.1.2. Metabolomics Market: By Application, 2022-2032, USD (Million)
9.5.1.1.3. Metabolomics Market: By Indication, 2022-2032, USD (Million)
9.5.1.2. Germany
9.5.1.2.1. Metabolomics Market: By Product and Services, 2022-2032, USD (Million)
9.5.1.2.2. Metabolomics Market: By Application, 2022-2032, USD (Million)
9.5.1.2.3. Metabolomics Market: By Indication, 2022-2032, USD (Million)
9.5.1.3. Spain
9.5.1.3.1. Metabolomics Market: By Product and Services, 2022-2032, USD (Million)
9.5.1.3.2. Metabolomics Market: By Application, 2022-2032, USD (Million)
9.5.1.3.3. Metabolomics Market: By Indication, 2022-2032, USD (Million)
9.5.1.4. Italy
9.5.1.4.1. Metabolomics Market: By Product and Services, 2022-2032, USD (Million)
9.5.1.4.2. Metabolomics Market: By Application, 2022-2032, USD (Million)
9.5.1.4.3. Metabolomics Market: By Indication, 2022-2032, USD (Million)
9.5.1.5. France
9.5.1.5.1. Metabolomics Market: By Product and Services, 2022-2032, USD (Million)
9.5.1.5.2. Metabolomics Market: By Application, 2022-2032, USD (Million)
9.5.1.5.3. Metabolomics Market: By Indication, 2022-2032, USD (Million)
9.5.1.6. Rest of Europe
9.5.1.6.1. Metabolomics Market: By Product and Services, 2022-2032, USD (Million)
9.5.1.6.2. Metabolomics Market: By Application, 2022-2032, USD (Million)
9.5.1.6.3. Metabolomics Market: By Indication, 2022-2032, USD (Million)

10. Asia Pacific Metabolomics Market, 2022-2032, USD (Million)
10.1. Market Overview
10.2. Metabolomics Market: By Product and Services, 2022-2032, USD (Million)
10.3. Metabolomics Market: By Application, 2022-2032, USD (Million)
10.4. Metabolomics Market: By Indication, 2022-2032, USD (Million)
10.5.Metabolomics Market: By Region, 2022-2032, USD (Million)
10.5.1.Asia Pacific
10.5.1.1. China
10.5.1.1.1. Metabolomics Market: By Product and Services, 2022-2032, USD (Million)
10.5.1.1.2. Metabolomics Market: By Application, 2022-2032, USD (Million)
10.5.1.1.3. Metabolomics Market: By Indication, 2022-2032, USD (Million)
10.5.1.2. Japan
10.5.1.2.1. Metabolomics Market: By Product and Services, 2022-2032, USD (Million)
10.5.1.2.2. Metabolomics Market: By Application, 2022-2032, USD (Million)
10.5.1.2.3. Metabolomics Market: By Indication, 2022-2032, USD (Million)
10.5.1.3. India
10.5.1.3.1. Metabolomics Market: By Product and Services, 2022-2032, USD (Million)
10.5.1.3.2. Metabolomics Market: By Application, 2022-2032, USD (Million)
10.5.1.3.3. Metabolomics Market: By Indication, 2022-2032, USD (Million)
10.5.1.4. Australia
10.5.1.4.1. Metabolomics Market: By Product and Services, 2022-2032, USD (Million)
10.5.1.4.2. Metabolomics Market: By Application, 2022-2032, USD (Million)
10.5.1.4.3. Metabolomics Market: By Indication, 2022-2032, USD (Million)
10.5.1.5. South Korea
10.5.1.5.1. Metabolomics Market: By Product and Services, 2022-2032, USD (Million)
10.5.1.5.2. Metabolomics Market: By Application, 2022-2032, USD (Million)
10.5.1.5.3. Metabolomics Market: By Indication, 2022-2032, USD (Million)
10.5.1.6. Rest of Asia Pacific
10.5.1.6.1. Metabolomics Market: By Product and Services, 2022-2032, USD (Million)
10.5.1.6.2. Metabolomics Market: By Application, 2022-2032, USD (Million)
10.5.1.6.3. Metabolomics Market: By Indication, 2022-2032, USD (Million)

11. Latin America Metabolomics Market, 2022-2032, USD (Million)
11.1. Market Overview
11.2. Metabolomics Market: By Product and Services, 2022-2032, USD (Million)
11.3. Metabolomics Market: By Application, 2022-2032, USD (Million)
11.4. Metabolomics Market: By Indication, 2022-2032, USD (Million)
11.5.Metabolomics Market: By Region, 2022-2032, USD (Million)
11.5.1.Latin America
11.5.1.1. Brazil
11.5.1.1.1. Metabolomics Market: By Product and Services, 2022-2032, USD (Million)
11.5.1.1.2. Metabolomics Market: By Application, 2022-2032, USD (Million)
11.5.1.1.3. Metabolomics Market: By Indication, 2022-2032, USD (Million)
11.5.1.2. Mexico
11.5.1.2.1. Metabolomics Market: By Product and Services, 2022-2032, USD (Million)
11.5.1.2.2. Metabolomics Market: By Application, 2022-2032, USD (Million)
11.5.1.2.3. Metabolomics Market: By Indication, 2022-2032, USD (Million)
11.5.1.3. Rest of Latin America
11.5.1.3.1. Metabolomics Market: By Product and Services, 2022-2032, USD (Million)
11.5.1.3.2. Metabolomics Market: By Application, 2022-2032, USD (Million)
11.5.1.3.3. Metabolomics Market: By Indication, 2022-2032, USD (Million)

12. Middle East and Africa Metabolomics Market, 2022-2032, USD (Million)
12.1. Market Overview
12.2. Metabolomics Market: By Product and Services, 2022-2032, USD (Million)
12.3. Metabolomics Market: By Application, 2022-2032, USD (Million)
12.4. Metabolomics Market: By Indication, 2022-2032, USD (Million)
12.5.Metabolomics Market: By Region, 2022-2032, USD (Million)
12.5.1.Middle East and Africa
12.5.1.1. GCC
12.5.1.1.1. Metabolomics Market: By Product and Services, 2022-2032, USD (Million)
12.5.1.1.2. Metabolomics Market: By Application, 2022-2032, USD (Million)
12.5.1.1.3. Metabolomics Market: By Indication, 2022-2032, USD (Million)
12.5.1.2. Africa
12.5.1.2.1. Metabolomics Market: By Product and Services, 2022-2032, USD (Million)
12.5.1.2.2. Metabolomics Market: By Application, 2022-2032, USD (Million)
12.5.1.2.3. Metabolomics Market: By Indication, 2022-2032, USD (Million)
12.5.1.3. Rest of Middle East and Africa
12.5.1.3.1. Metabolomics Market: By Product and Services, 2022-2032, USD (Million)
12.5.1.3.2. Metabolomics Market: By Application, 2022-2032, USD (Million)
12.5.1.3.3. Metabolomics Market: By Indication, 2022-2032, USD (Million)

13. Company Profile
13.1. Agilent Technologies, Inc.
13.1.1. Company Overview
13.1.2. Financial Performance
13.1.3. Product Portfolio
13.1.4. Strategic Initiatives
13.2. Acureomics AB
13.2.1. Company Overview
13.2.2. Financial Performance
13.2.3. Product Portfolio
13.2.4. Strategic Initiatives
13.3. Amatsi Group
13.3.1. Company Overview
13.3.2. Financial Performance
13.3.3. Product Portfolio
13.3.4. Strategic Initiatives
13.4. Bayer, Inc.
13.4.1. Company Overview
13.4.2. Financial Performance
13.4.3. Product Portfolio
13.4.4. Strategic Initiatives
13.5. Berg LLC
13.5.1. Company Overview
13.5.2. Financial Performance
13.5.3. Product Portfolio
13.5.4. Strategic Initiatives
13.6. Biocrates Life Sciences AG
13.6.1. Company Overview
13.6.2. Financial Performance
13.6.3. Product Portfolio
13.6.4. Strategic Initiatives
13.7. Bio-Rad Laboratories, Inc.
13.7.1. Company Overview
13.7.2. Financial Performance
13.7.3. Product Portfolio
13.7.4. Strategic Initiatives
13.8. Bruker Corporation
13.8.1. Company Overview
13.8.2. Financial Performance
13.8.3. Product Portfolio
13.8.4. Strategic Initiatives
13.9. Chenomx,Inc
13.9.1. Company Overview
13.9.2. Financial Performance
13.9.3. Product Portfolio
13.9.4. Strategic Initiatives
13.10. Danher Corporation
13.10.1. Company Overview
13.10.2. Financial Performance
13.10.3. Product Portfolio
13.10.4. Strategic Initiatives
13.11. Human Metabolome Technologies, Inc.
13.11.1. Company Overview
13.11.2. Financial Performance
13.11.3. Product Portfolio
13.11.4. Strategic Initiatives
13.12. HepatoChem, Inc.
13.12.1. Company Overview
13.12.2. Financial Performance
13.12.3. Product Portfolio
13.12.4. Strategic Initiatives
13.13. IROA Technologies
13.13.1. Company Overview
13.13.2. Financial Performance
13.13.3. Product Portfolio
13.13.4. Strategic Initiatives
13.14. Leco Corporation
13.14.1. Company Overview
13.14.2. Financial Performance
13.14.3. Product Portfolio
13.14.4. Strategic Initiatives
13.15. Metabolon, Inc.
13.15.1. Company Overview
13.15.2. Financial Performance
13.15.3. Product Portfolio
13.15.4. Strategic Initiatives
13.16. Max Planck Society
13.16.1. Company Overview
13.16.2. Financial Performance
13.16.3. Product Portfolio
13.16.4. Strategic Initiatives
13.17. Metabolomic Discoveries GmbH
13.17.1. Company Overview
13.17.2. Financial Performance
13.17.3. Product Portfolio
13.17.4. Strategic Initiatives
13.18. Metabolomx
13.18.1. Company Overview
13.18.2. Financial Performance
13.18.3. Product Portfolio
13.18.4. Strategic Initiatives
13.19. Metabometrix Ltd.
13.19.1. Company Overview
13.19.2. Financial Performance
13.19.3. Product Portfolio
13.19.4. Strategic Initiatives
13.20. Metanomics GmbH
13.20.1. Company Overview
13.20.2. Financial Performance
13.20.3. Product Portfolio
13.20.4. Strategic Initiatives
13.21. Phenomenome Discoveries, Inc.
13.21.1. Company Overview
13.21.2. Financial Performance
13.21.3. Product Portfolio
13.21.4. Strategic Initiatives
13.22. SCIEX
13.22.1. Company Overview
13.22.2. Financial Performance
13.22.3. Product Portfolio
13.22.4. Strategic Initiatives
13.23. Shimadzu Corporation
13.23.1. Company Overview
13.23.2. Financial Performance
13.23.3. Product Portfolio
13.23.4. Strategic Initiatives
13.24. SiDMAP
13.24.1. Company Overview
13.24.2. Financial Performance
13.24.3. Product Portfolio
13.24.4. Strategic Initiatives
13.25. Stemina Biomarker Discovery, Inc
13.25.1. Company Overview
13.25.2. Financial Performance
13.25.3. Product Portfolio
13.25.4. Strategic Initiatives
13.26. Thermo Fisher Scientific, Inc.
13.26.1. Company Overview
13.26.2. Financial Performance
13.26.3. Product Portfolio
13.26.4. Strategic Initiatives
13.27. Waters Corporation
13.27.1. Company Overview
13.27.2. Financial Performance
13.27.3. Product Portfolio
13.27.4. Strategic Initiatives
13.28. Xceleron, Inc.
13.28.1. Company Overview
13.28.2. Financial Performance
13.28.3. Product Portfolio
13.28.4. Strategic Initiatives
13.29. Other Notable Players
13.29.1. Company Overview
13.29.2. Financial Performance
13.29.3. Product Portfolio
13.29.4. Strategic Initiatives